Health Catalyst (HCAT) Revenue (2018 - 2026)

Health Catalyst's Revenue history runs 9 years deep, the most recent figure standing at $70.8 million for Q1 2026.

• Quarterly Revenue fell 10.9% year-over-year to $70.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $302.5 million (down 2.83% YoY) and the FY2025 annual result came in at $311.1 million, up 1.48% from the prior year.
• Revenue was $70.8 million for Q1 2026 at Health Catalyst, down from $74.7 million in the prior quarter.
• Across five years, Revenue topped out at $80.7 million in Q2 2025 and bottomed at $68.1 million in Q1 2022.
• A 5-year average of $74.2 million and a median of $74.7 million in 2025 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue grew 21.92% — and 2026, when it dropped 10.9%.
• Health Catalyst's Revenue stood at $69.2 million in 2022, then grew by 8.56% to $75.1 million in 2023, then climbed by 6.02% to $79.6 million in 2024, then declined by 6.19% to $74.7 million in 2025, then fell by 5.25% to $70.8 million in 2026.
• Business Quant data shows HCAT's Revenue at $70.8 million in Q1 2026, $74.7 million in Q4 2025, and $76.3 million in Q3 2025.